<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> have a high frequency of mid-pregnancy <z:hpo ids='HP_0001511'>intrauterine growth retardation</z:hpo> or fetal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The authors report the case of a 28 year old pregnant woman with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> with severe obstetrical complications (<z:hpo ids='HP_0005268'>spontaneous abortion</z:hpo>, <z:e sem="disease" ids="C0000814" disease_type="Disease or Syndrome" abbrv="">missed abortion</z:e>) in the past history </plain></SENT>
<SENT sid="2" pm="."><plain>By means of the administration of combined immunomudulant (intravenous immunoglobulin, steroid), <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and antiplatelet therapy we could prevent a subsequent pregnancy loss of the patient </plain></SENT>
<SENT sid="3" pm="."><plain>Apropos of this case the authors give an overview on the monitoring of the disease and the therapeutical recommendations of the literature </plain></SENT>
</text></document>